Egr-1 is not upregulated in response to hypoxic and oxygenation conditions in human glioblastoma in vitro

Molecular Medicine Reports

Volumn 2, Issue 5, 2009, Pages 757-763

  Said, Harun M ^a   Polat, Buelent ^a   Hagemann, Carsten ^a   Vince, Giles H ^a   Anacker, Jelena ^a   Kämmerer, Ulrike ^a   Flentje, Michael ^a   Vordermark, Dirk ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Early growth response factor 1; Glioblastoma; Hypoxia; Hypoxia inducible factor 1 ; N Myc downregulated gene 1; Reoxygenation

Indexed keywords

BETA ACTIN; BETA TUBULIN; DEFEROXAMINE; EARLY GROWTH RESPONSE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

ADULT; AERATION; ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 69249202460     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000169     Document Type: Article

References (31)

1. Akutagawa O, Nishi H, Kyo S, Terauchi F, Yamazawa K, Higuma C, Inoue M and Isaka K: Early growth response-1 mediates downregulation of telomerase in cervical cancer. Cancer Sci 99: 1401-1406, 2008. (Pubitemid 351761730)
2. Zhang P, Tchou-Wong KM and Costa M: Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67: 9125-9133, 2007. (Pubitemid 47535898)
3. Ellen T, Ke Q, Zhang P and Costa M: NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29: 2-8, 2008. (Pubitemid 351201735)
4. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
5. Iwai K, Yamanaka K, Kamura T, et al: Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96: 12436-12441, 1999. (Pubitemid 29513520)
6. Lisztwan J, Imbert G, Wirbelauer C, Gstaiger M and Krek W: The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity. Genes Dev 13: 1822-1833, 1999.
7. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ and Maxwell PH: Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275: 25733-25741, 2000. (Pubitemid 30687077)
8. Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC and Conaway JW: Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA 97: 10430-10435, 2000. (Pubitemid 30707283)
9. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V and Kaelin WG: Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2: 423-427, 2000. (Pubitemid 30781067)
10. Tanimoto K, Makino Y, Pereira T and Poellinger L: Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J 19: 4298-4309, 2000. (Pubitemid 30623741)
11. Melillo G, Musso T, Sica A, Taylor LS, Cox GW and Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683-1693, 1995.
12. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ and Harris AL: Targeting gene expression to hypoxic tumor cells. Nat Med 3: 515-520, 1997. (Pubitemid 27198648)
13. Gu YZ, Hogenesch JB and Bradfield CA: The PAS superfamily: sensors of environmental and developmental signals. Ann Rev Pharmacol Toxicol 40: 519-561, 2000.
14. Said HM, Polat B, Hagemann C, et al: Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro. Oncol Rep 20: 413-419, 2008.
15. Said HM, Stein S, Hagemann C, et al: Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. Oncol Rep 21: 237-246, 2009.
16. Said H, Stein S, Staab A, Katzer A, Flentje M and Vordermark D: NDRG1 is regulated in human glioblastoma in vitro as a consequence to the changing concentrations of the oxygen microenviroment. FEBS J 273 (s1): 345, 2006.
17. Said HM, Stein S, Hagemann C, Polat B, Schömig B, Staab A, Theobald M, Flentje M and Vordermark D: NDRG1 regulation as a response to an alternating hypoxic microenviroment in vivo and in vitro in human brain tumors. FEBS J 274 (S1): 281, 2007.
18. Akslen LA, Andersen KJ and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-803, 1988.
19. Vordermark D, Katzer A, Baier K, Kraft P and Flentje M: Cell type-specific association of hypoxia-inducible factor-1α (HIF-1α) protein accumulation and radiobiologic tumor hypoxia. Int J Radiat Oncol Biol Phys 58: 1242-1250, 2004. (Pubitemid 38314810)
20. Said HM, Hagemann C, Staab A, Stojic J, Kühnel S, Vince GH, Flentje M, Roosen K and Vordermark D: Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother Oncol 83: 398-405, 2007. (Pubitemid 46907985)
21. Hagemann C, Anacker J, Gerngras S, Kühnel S, Said HM, Patel R, Kämmerer U, Vordermark D, Roosen K and Vince GH: Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas. Oncol Rep 20: 301-308, 2008.
22. Said HM, Katzer A, Flentje M, et al: Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol 76: 200-205, 2005. (Pubitemid 41725448)
23. Dooley S, Said HM, Gressner AM, et al: Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281: 1784-1795, 2006. (Pubitemid 43752497)
24. Said HM, Hagemann C, Stojic J, et al: GAPDH is not regulated in human glioblastoma under hypoxic conditions. BMC Mol Biol 8: 55, 2007. (Pubitemid 47074149)
25. Said HM, Staab A, Hagemann C, et al: Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. J Neurooncol 81: 27-38, 2007. (Pubitemid 44963986)
26. Liao H, Hyman MC, Lawrence DA and Pinsky DJ: Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J 21: 935-949, 2007.
27. Manalo DJ, Rowan A, Lavoie T, et al: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669. 2005. (Pubitemid 40070750)
28. Ravi R, Mookerjee B, Bhujwalla ZM, et al: Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor la. Genes Dev 14: 34-44, 2000. (Pubitemid 30051577)
29. Greijer AE, van der Groep P, Kemming D, et al: Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206: 291-304, 2005. (Pubitemid 40903193)
30. Said HM, Hagemann C, Anacker J, Stein S, Polat B, Staab A, Flentje M, Theobald M, Roosen K and Vordermark D: Analysis of HIF-1alpha regulated gene expression in human brain tumors. FEBS J 275 (Suppl 1): 344, 2008.
31. Yan SF, Lu J, Zou YS, Soh-Won J, Cohen DM, Buttrick PM, Cooper DR, Steinberg SF, Mackman N, Pinsky DJ and Stern DM: Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 274: 15030-15040, 1999. (Pubitemid 129518837)